Clinical trial
Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications
NCT05463705 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 4, 2023
- Completion date
- August 22, 2024
- Enrollment
- 1,580 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes, diffusion of responsibility, prescribing burden, sglt-2i and glp-1ra therapies